Larger scale separation technologies, such as those used in the pharmaceutical and diagnostics industry, have historically grappled with the high cost of availing research grade MBA at economically feasible prices. This has driven larger consumers to procure a low purity product when purchasing in bulk quantities.
SRL has been working on resolving this industry limitation and has successfully established itself as one of the only companies in India manufacturing MBA in ton lot batches. In doing so the Company specially emphasizes a high product purity of 99.5% and absence of DNA, RNA and protease impurities. It is the first time ever that an Indian company has managed a technology transfer for this product quality on such a scale.
With the current global pharmaceutical focus on peptides and specialty protein research, the development of cost-effective superior grade MBA has the potential to significantly reduce the cost of manufacturing specialized intermediates, drugs and diagnostic products.
